I N V E S T O R O V E R V I E W
Our vision is to grow and diversify our parent company, Envirosafe Chemicals Canada to expand our offering with Curativa Cannabis, as a division of Envirosafe Chemicals Canada, by diversifying into the medical marijuana industry, to increase our revenue and offer a significant return for our investors.
Our goal is to cultivate and produce high-quality, clean cannabis products for medicinal use. We will provide commercial-scale cannabis with an unmatched level of environmental control, to develop, refine, and repeat specific growth conditions.
With historical industrial production experience, and significant knowledge of marijuana production, we aim to be a leader in the cannabis industry and evolve with the needs of our consumers.
Our controlled growth strategy for our production facility with potential annual revenues of $15M for 10,000 grams per annum produced the first year, with increased growth potential annual revenues thereafter to $42M for 28,000 grams per annum produced.
Fortunes will be made as international medical cannabis markets balloon to $142B+ over the next 15 years. The Canadian market is HERE and NOW, with growing acceptance, increasing evidence of effectiveness, and political environment favourable for legislation.
To maximize profits in this space, investors should have direct exposure to licensed Canadian medical cannabis producers.
Opportunity for investment in Canada, in particular Saskatchewan and northern Canada is nearly untapped, and nationally medical marijuana production as current supply cannot meet demand.
If legislation in Canada legalizes recreational marijuana use, we will be prepared to expand into the same.
Will you become a marijuana millionaire?
I N V E S T O R P R E S E N T A T I O N
Start growing your investment today!
The Canadian Marijuana Index tracks the leading cannabis stocks operating in Canada. Constituents must have a business strategy focused on the marijuana or hemp industry, and are required to meet minimum trading criteria. The Index is equal-weighted and rebalanced quarterly.